Jundishapur Journal of Natural Pharmaceutical Products

Browse

Recent Submissions

Now showing 1 - 2 of 2
  • Item
    A COMPARISON BETWEEN IONIC AND NONIONIC CONTRAST NEPHROPATHY AMONG HIGH RISK PATIENTS CANDIDATE FOR CORONARY ANGIOGRAPHY
    (Brieflands, 2006-12-20) p alavinejad; H Shahbazian
    : Among the causes of nephrotoxic acute renal failure, the increase use of contrast agents has caused the contrast nephropathy to come second after aminoglycosides. The aim of this study is comparison of nephrotoxicity of ionic (Urografin) and nonionic (Omnipaque, Ultravist) contrast agents in high risk patients candidate for coronary angiography. In this study 82 high risk patients who were candidate for coronary angiography in a 6 months period in the year 2004 in Golestan hospital of Ahwaz were randomly divided into two equall groups – ionic and nonionic contrast agents – and the prevalence of contrast nephropathy in each group was determined. Electrolyte changes ( Na, K ) of these patients were also assessed. Plasma level of BUN, Cr, Na and K were measured before and 24 to 48 h after angiography and it was accounted as contrast nephropathy if Cr level has raised at least 0.5 mg. Among 41 patients who undergone angiography with nonionic agents (Omnipaque, Ultravist), 2 patients (5%) were affected by contrast nephropathy while this complication was seen in 6 patients (14.6%) among those who undergone angiography with ionic contrast agent (Urografin). No significant changes were seen in electrolyte concentration (Na, K) before and after angiography. Noting the fact that the predictive value of this finding is 0.132 (P>0.05), the statistical value of this is not proved. Therfore, there is no diffrence in nephrotoxicity between ionic and non-ionic contrast nephropathy in high risk patients. The most common risk factors of this complication were diabetes mellitus (DM) 50%, age≥65, 50% and chronic renal failure 25%. Relative risk (RR) of DM was 1.16, for old age 1.1 and it was 1.49 for chronic renal failure (CRF). The results of this study were similar to the results of American college of cardiology metaanalysis, Shwab study in USA and Esnalt study in France.
  • Item
    Effect of Malva sylvestris Extract on Postoperative Peritoneal Adhesion in Rats
    (Brieflands, 2019-08-31) Vahid Jomezadeh; Sima Sheibani; Alireza Tavassoli; Asieh Karimani; Mohammad Reza Zirak; Amir Hooshang Mohammadpour; Mohammad Reza Khakzad; Mohammad Afshar; Fatemeh Tavassoli
    Background: Postoperative peritoneal adhesion occurs in more than 90% of intra-abdominal surgeries and can lead to intestinal obstruction, infertility, abdominal and pelvic pain. The extract of Malva sylvestris has shown to be safe and non-toxic with a wide range of biological activities. Objectives: This study was designed to evaluate the effect of intraperitoneal nebulization of M. sylvestris in the healing process of postoperative intra-abdominal adhesion for the first time. Methods: For creating intra-abdominal adhesions, the rats were anesthetized to undergo surgery. Four lavage solutions including saline, ethanolic extract, hydroalcoholic extract, and aqueous extract of M. sylvestris were used for 2 min, and then the abdomen was closed. After 15 days, the rats underwent surgery and cecum and peritoneal samples were obtained for histopathological analysis. The severity of peritoneal adhesions based on the histopathological analysis and serum levels of TNF-α and Il-1β were compared in different groups. Results: The aqueous and hydroalcoholic extracts of M. sylvestris decreased significantly microscopic and macroscopic peritoneal adhesion while the ethanolic extract just reduced it microscopically. The aqueous and hydroalcoholic extracts were more potent than the ethanolic extract in the healing process. The concentrations of inflammatory biomarkers including IL-1β and TNF-α did not change significantly. Conclusions: The extract of M. sylvestris could decrease the severity of peritoneal adhesion compared to the control group but it could not decrease the level of systemic inflammatory mediators.